Blog Posts

Assessing The Value Of Wearables In Interventional Clinical Trials

Posted by | Fuld & Company

This assessment of Wearables in clinial trials was originally published in: Clinical Leader

Health-Wearable-Smart-Watch

Advancements in biosensor technology are becoming increasingly common in the consumer space, with wrists adorned with Fitbits or similar devices, clothing embedded with “intelligent” fibers, and personal safety devices seen in healthcare facilities across the nation. Our culture is increasingly accustomed to tracking health metrics through smartphones and simple recreational wearables. In the pharmaceutical space, we are now seeing where success in the consumer segment can translate to value-adds through wearables in clinical trials.

In traditional pharmaceutical interventional clinical trials, collection of data for primary and secondary endpoints (objective and/or subjective) must take place in a clinical setting to maximize quality control and meet FDA requirements. In some cases, the FDA allows secondary endpoint data to be collected remotely (usually in the home setting), often through questionnaires completed by patients and/or their caregivers. Such data are usually subjective and as such are typically not sufficient for primary endpoint analysis in interventional trials. Novel wearable biosensors change the calculus by creating the opportunity to collect objective data outside the clinic.

Fuld & Company’s Life Science Consulting practice spans pharmaceuticals, biotechnology, diagnostics, medical device, health IT, and healthcare payers and providers.

Tags: , , , , , ,

Related Resources

Read More

Reflections from Big Data LDN 2025: What Will Shape the Next Wave of AI & Analytics? 

Big Data LDN 2025 was buzzing with energy. Over two days, thousands of practitioners, technologists, and business leaders came together […]

Read More

​Fuld Strengthens Leadership with Appointment of Anurag Kapoor as Chief Analytics & AI Officer

BOSTON – SEPT 10, 2025 – Fuld, a global leader in Analytics & AI and competitive strategy, today appointed Anurag […]

Read More

Reflections from the Road: Navigating the New Era of Private Credit

Six weeks. Eleven cities. More than 30 conversations with lower-middle and middle-market private credit firms.  If there’s one thing my […]

Subscribe to our mailing list for our latest updates:

Subscribe Now